Skip to main content
Sreekanth Vemulapalli, MD, Cardiology, Durham, NC

Sreekanth Vemulapalli MD

Adult Congenital Heart Disease, Interventional Cardiology


Cardiology, Duke University Medical Center

Join to View Full Profile
  • 40 Duke Medicine CirDurham, NC 27710

  • Phone+1 919-684-8111

Dr. Vemulapalli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 2009 - 2013
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - Present
  • NC State Medical License
    NC State Medical License 2009 - 2026
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Volume-Outcome Association of Mitral Valve Surgery in the United States  
    Sreekanth Vemulapalli, MD, JAMA Cardiology
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States  
    Guillaume Marquis-Gravel, Vinod H Thourani, Thomas G Gleason, Ajay J Kirtane, Sreekanth Vemulapalli, JAMA Cardiology
  • Focus on Transcatheter Aortic Valve Replacement Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic...  
    Jonathan P Piccini, Vinod H Thourani, Samir Kapadia, David Cohen, Eric Peterson, Matthew W Sherwood, Ajay Kirtane, Sreekanth Vemulapalli, Amit N Vora, Bhaskar Bhardwaj, ScienceDirect
  • Join now to see all

Abstracts/Posters

  • [Board 017] Pre Versus Post-Procedure Clinical Event Rates and Associated Healthcare Resource Utilization in Patients Undergoing Commercial MitraClip Placement
    Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
  • [Board 473] Impact of Surgical Intervention on Healthcare Utilization in Patients With Non-Rheumatic Tricuspid Valve Disease
    Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
  • [Board 474] Comorbidities and Outcomes in Patients With Non-Rheumatic Tricuspid Valve Disease
    Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Insights into the PRECISE Randomized Clinical Trial 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • Engage @ACC. Studio: Vascular Innovation Shark Tank 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Is Renal Artery Intervention Dead? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Join now to see all

Authored Content

  • Volume-Outcome Association of Mitral Valve Surgery in the United StatesJuly 2020
  • Volume-Outcome Association of Mitral Valve Surgery in the United StatesJuly 2020
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United StatesJune 2020
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United StatesJune 2020
  • Join now to see all

Press Mentions

  • Is Volume an Accurate Measure of Success When It Comes to Mitral Valve Surgery?
    Is Volume an Accurate Measure of Success When It Comes to Mitral Valve Surgery?November 22nd, 2019
  • Non-Continuous Care After TAVR Tied to Poorer Outcome
    Non-Continuous Care After TAVR Tied to Poorer OutcomeJuly 24th, 2019
  • Fragmented TAVR Care Common, Linked to Death and Readmission
    Fragmented TAVR Care Common, Linked to Death and ReadmissionJuly 8th, 2019
  • Join now to see all

Grant Support

  • 2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)DUKE UNIVERSITY2023–2030
  • 2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)DUKE UNIVERSITY2023–2030
  • 2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)DUKE UNIVERSITY2024–2029
  • 2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)DUKE UNIVERSITY2024–2029
  • Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular DisordersDUKE UNIVERSITY2024–2028
  • Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular DisordersDUKE UNIVERSITY2024–2028
  • BEST-VIVA Registry (vCLI)DUKE UNIVERSITY2019–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: